h
PSC
reg
®
Home
Browse
All cell lines
All hiPSC lines
All hESC lines
Cell line providers
Research projects
Countries
Diseases
Publications
Clinical studies
Info
About hPSCreg
FAQ
Cell Registration
Glossary
Documents & Governance
Fact Sheets
Naming Tool
Publishing your line
Structures
Registration Summary
Certification
API
Export Data
SPARQL Guide
Contact
News
Newsletter Subscription
Privacy Policy
Terms of Use
Imprint
Login
Log-in
Sign up
Forgot your password?
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our
Privacy Policy
for details.
This website uses cookies,
learn more
x
KUIMSe004-A
Registration Summary
:
A
P
E
C
KthES11
The cell line is
not submitted
yet.
(only basic data is shown)
General
Cell Line
hPSCreg name
KUIMSe004-A
Cite as:
When citing this cell line, please use the hPSCreg name (see
Naming Tool
) and the corresponding Research Resource ID (RRID).
KUIMSe004-A (RRID:CVCL_UM06)
Alternative name(s)
KthES11
Cell line type
Human embryonic stem cell (hESC)
Similar lines
No similar lines found.
Last update
15th June 2021
User feedback
show/hide
Written by
on
Delete
No feedback available yet.
Login
to share your feedback, experiences or results with the research community.
Provider
Generator
Kyoto University (KUIMS)
External Databases
Cellosaurus
CVCL_UM06
Wikidata
Q95980472
General Information
Publications
Kawase E et al. Generation of clinical-grade human embryonic stem cell line KthES11 according to Japanese regulations. Stem cell research. 2021 Jul;54:102383.
(reference publication)
Umezawa A et al. Research and Development Strategy for Future Embryonic Stem Cell-Based Therapy in Japan. JMA journal. 2020 Oct 15;3(4):287-294.
Kawase E et al. Kyoto hESC cell resource for regenerative medicine. Stem cell research. 2020 Dec;49:102020.
Yuzuriha A et al. Extracellular laminin regulates hematopoietic potential of pluripotent stem cells through integrin β1-ILK-β-catenin-JUN axis. Stem cell research. 2021 May;53:102287.
Takada K et al. Efficient derivation and banking of clinical-grade human embryonic stem cell lines in accordance with Japanese regulations. Regenerative therapy. 2022 Dec;21:553-559.
Login to share your feedback, experiences or results with the research community.